Podlipodcast player Webplayer

The Catalyst Clinic: The Science of Age-less Living

The Catalyst Clinic: The Science of Age-less Living

Why Aren’t We Age-less? The Molecular Receipt for Being Young

The Catalyst Clinic: The Science of Age-less Living · Oct 25, 2026 · 21:41

0:0021:41

Listen in the Podli app 🎧

Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.

This episode Dr Ethan asks a deceptively simple question — why do we age and die on a predictable schedule? — and answers it by weaving together molecular biology and evolutionary theory. It opens by dismantling the myth that ancient humans never grew old (a distortion caused by averaging in high child mortality), showing via Gompertz’s 1825 mortality curve that adult death risk doubles on a fixed interval of roughly eight years. It then traces the discovery that aging is written partly into our cells: Carrel’s seemingly immortal chicken-heart culture, overturned by Hayflick’s finding that normal human cells divide about fifty times and then enter senescence — a state enforced by the cell-cycle brakes p16 (CDKN2A) and p21 (CDKN1A) and broadcast through the NF-κB-driven inflammatory SASP, contributing to “inflammaging.”

The molecular thread continues with telomeres — the TTAGGG caps that shorten each division because DNA polymerase can’t copy the very end of a strand — and the enzyme telomerase (TERT/TERC) that can rebuild them. The twist is that the body keeps telomerase switched off in most cells as an anti-cancer safeguard, since ~90% of tumours reactivate it. The same logic governs p53 (TP53), the “guardian of the genome”: the 2002 Houston mouse experiment showed that extra p53 cut cancer but accelerated aging, the clearest real example of antagonistic pleiotropy — a gene that protects the young at the cost of the old. The episode then shifts to evolutionary explanations: Medawar’s selection shadow (late-acting harmful genes escape selection because few ancestors lived long enough to suffer them), Williams’s trade-off principle, and Kirkwood’s disposable soma theory.

Finally, the predictions are tested in the wild — Austad’s longer-lived predator-free Sapelo Island opossums, long-lived bats and naked mole rats — and in our own past, where Caspari’s wisdom-tooth analysis shows a surge in humans reaching grandparent age ~30,000 years ago, tied to safer living and the grandmother hypothesis. The conclusion unifies all four clues: selection buys protection for the young, and danger sets how much it spends on the old. The host closes on the experimental frontier of senolytics — compounds targeting the BCL-2 survival proteins (fisetin, dasatinib-plus-quercetin, FOXO4–p53-disrupting peptides) — with an explicit caveat that none are approved anti-aging therapies and that the honest stance is hope without hype.

Episodes: The Catalyst Clinic: The Science of Age-less Living

PodliGet the free Podli app
↓ App